European Pharma and Nutra Industries Uphold Great Potential in the Coming Years: Expert Says
European Pharma and Nutra Industries Uphold Great Potential in the Coming Years: Expert Says

European Pharma and Nutra Industries Uphold Great Potential in the Coming Years: Expert Says

  • 18-Oct-2022 11:00 AM
  • Journalist: Robert Hume

The market for nutraceutical ingredients is constantly expanding around the globe due to growing consumer preference for natural food products, probiotic dietary supplements, growing consumer concern over preventative healthcare, rising consumer interest in functional foods, and an increase in the prevalence of chronic diseases among the population. On the other hand, the market's expansion is being hampered by the high cost of producing nutraceutical components. As per industry experts, future market potential will be increased by higher R&D spending to investigate novel applications for components used in nutraceuticals and by government activities to promote their use.

The global community is becoming more and more interested in sustainability because it is all about striking a balance between economic performance with social and ecological responsibility. The footprint of the pharmaceutical and biotechnology sectors is roughly identical to that of the auto sector. On the other side, the European Union administration has done some extremely commendable actions. For instance, the EU Green Deal mandated that the EU achieve carbon neutrality by 2050. In Germany, companies are using the law to attempt and reach this objective five years in advance. It is high time that we must take action and launch the first steps to lessen our environmental impact. While it does cost money, it ultimately benefits much.

Sara Lesina was recently selected as the new General Manager (GM) in Europe by the international nutraceutical Contract Development and Manufacturing Organization (CDMO) to advance a strategy aimed at small and medium companies releasing revolutionary and novel nutraceutical formulations. The hiring of Lesina intends to boost the organization's ambition to establish itself as the nutraceutical R&D hub for brands searching for flexible partners with significant scientific and development resources. She states, "I expect tremendous development for SIRIO, a leading worldwide nutraceutical sector, specialized in designing and manufacturing finest quality goods including gummies made from Melatonin, Vitamins, etc., as customers will discover the benefits of partnering with an agile CDMO partner. 

Lesina said in her statement that the company would spend time and money developing nutraceuticals that will not only properly deliver doses but also be pleasing to the consumer, with flavor, texture, and appearance playing an important role in the development process. As a development and production partner, the company foresees numerous areas with significant potential for international expansion in Europe.

Related News

Melatonin Market Downturns in Q2 After Being Optimistic From the Beginning of 2023
  • 29-May-2023 12:06 PM
  • Journalist: Shiba Teramoto
High Demand Runs the Gamut of Melatonin Prices in the US
  • 17-Feb-2023 2:05 PM
  • Journalist: Shiba Teramoto
Melatonin Market Set to a Terrific Start in 2023 After a Continuous Drop Amid Recession Fears
  • 18-Jan-2023 4:10 PM
  • Journalist: Jacob Kutchner
The U.S. Market Continues to Witness a Decline in the Melatonin Prices
  • 28-Nov-2022 5:51 PM
  • Journalist: Henry Locke